Press Releases

Active Biotech AB - Interim report January - June 2017
August 10, 2017 08:30 (CEST)
Regulatory
Helén Tuvesson new CEO of Active Biotech AB from July 1, 2017
June 19, 2017 15:30 (CEST)
Regulatory
Annual General Meeting of Active Biotech AB
June 16, 2017 08:30 (CEST)
Regulatory
Annual Report 2016 Active Biotech AB (publ)
May 18, 2017 14:30 (CEST)
Regulatory
Active Biotech: Notice of Annual General Meeting of Shareholders
May 17, 2017 08:30 (CEST)
Regulatory
Teva and Active Biotech Announce CONCERTO trial of Laquinimod in RRMS Did Not Meet Primary Endpoint
May 5, 2017 20:00 (CEST)
Regulatory
Active Biotech: Interim report January - March 2017
April 27, 2017 08:30 (CEST)
Regulatory
Active Biotech: FDA grants Orphan Drug Designation for tasquinimod for the treatment of multiple myeloma
April 12, 2017 13:30 (CEST)
Regulatory
Active Biotech AB Year-end report January - December 2016
February 16, 2017 08:30 (CET)
Regulatory
The European Patent Office grants patent for tasquinimod for treatment of multiple myeloma
January 9, 2017 13:00 (CET)
Regulatory